XML 129 R110.htm IDEA: XBRL DOCUMENT v3.8.0.1
Equity-Based Compensation Plans (Narrative) (Details) - USD ($)
1 Months Ended 12 Months Ended 36 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2017
Stock based compensation expense       $ 1,095,000 $ 714,000 $ 710,000  
Stock based compensation, income tax benefit       405,000 264,000 277,000  
Proceeds from stock options exercised       $ 287,000 375,000 112,000  
Restricted Stock [Member] | Subsequent Event [Member]              
Stock based compensation expense     $ 733,000        
First Bancorp Plans [Member]              
Vesting period       10 years      
Exercise price range - floor       $ 14.35      
Exercise prices range - ceiling       $ 16.81      
Stock options outstanding       38,689     38,689
First Bancorp Plans [Member] | 2014 Equity Plan [Member]              
Shares remaining available for grant       809,690     809,690
Director [Member]              
Stock based compensation expense       $ 320,000      
Employees Grants [Member]              
Stock based compensation expense       775,000      
Non-Employee Directors [Member]              
Stock based compensation expense $ 320,000 $ 129,000          
Shares granted to directors 11,190 6,584          
Shares granted per director 1,119 823          
Shares granted to directors, Per share $ 28.59 $ 19.56          
Senior Executives [Member] | Restricted Stock [Member]              
Total compensation expense associated with senior executives grants       758,000     $ 758,000
Stock based compensation expense       $ 282,000 220,000 93,000  
Vesting period       3 years      
Grants in period (options)             55,648
Percent of bonus earned under the incentive plan in cash       50.00%      
Percent of bonus earned under the incentive plan in shares of restricted stock       50.00%      
Employees [Member]              
Stock based compensation expense       $ 491,000 $ 366,000 $ 488,000 $ 2,800,000
Vesting period             3 years
Grants in period (options)             130,059